A detailed history of Allspring Global Investments Holdings, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 689,986 shares of NBIX stock, worth $86.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
689,986
Previous 710,600 2.9%
Holding current value
$86.6 Million
Previous $97.8 Million 18.8%
% of portfolio
0.13%
Previous 0.16%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$114.58 - $153.15 $2.36 Million - $3.16 Million
-20,614 Reduced 2.9%
689,986 $79.4 Million
Q2 2024

Jul 26, 2024

BUY
$130.86 - $143.19 $26.7 Million - $29.2 Million
203,934 Added 40.25%
710,600 $97.8 Million
Q1 2024

Apr 18, 2024

BUY
$130.4 - $143.74 $12.6 Million - $13.9 Million
96,563 Added 23.55%
506,666 $69.9 Million
Q4 2023

Jan 25, 2024

BUY
$106.07 - $132.76 $19.6 Million - $24.5 Million
184,660 Added 81.91%
410,103 $54 Million
Q3 2023

Oct 27, 2023

BUY
$94.02 - $117.1 $21.2 Million - $26.4 Million
225,443 New
225,443 $25.4 Million
Q2 2023

Jul 18, 2023

BUY
$89.53 - $104.87 $2.83 Million - $3.31 Million
31,590 Added 9.35%
369,604 $34.9 Million
Q1 2023

Apr 13, 2023

SELL
$94.11 - $123.02 $14.9 Million - $19.5 Million
-158,179 Reduced 31.88%
338,014 $34.2 Million
Q4 2022

Jan 23, 2023

SELL
$106.72 - $127.06 $4.57 Million - $5.44 Million
-42,846 Reduced 7.95%
496,193 $0
Q3 2022

Oct 26, 2022

BUY
$92.03 - $107.81 $39.3 Million - $46 Million
426,675 Added 379.73%
539,039 $57.3 Million
Q2 2022

Jul 25, 2022

SELL
$75.79 - $100.07 $6.85 Million - $9.05 Million
-90,391 Reduced 44.58%
112,364 $11 Million
Q1 2022

May 02, 2022

SELL
$72.45 - $94.81 $167,431 - $219,105
-2,311 Reduced 1.13%
202,755 $19 Million
Q4 2021

Jan 28, 2022

BUY
$79.65 - $106.22 $16.3 Million - $21.8 Million
205,066 New
205,066 $17.5 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.